The Medicines Company

Pharma-Care, Inc. and its family of companies have been serving the health care field since 1976, offering high-quality and cost-effective services to their clients. With a multidisciplinary approach and a commitment to meeting the changing needs of the industry, their specialists provide unique solutions to diverse problems, ensuring that the public receives optimal care. Pharma-Care, Inc. is dedicated to staying at the forefront of technology, offering services such as Electronic Medical Records and EPIC Services or IMRR Services, which eliminate the need for faxing and expedite the review process. Their expertise and innovative approach make them a trusted partner in the health care industry.Generated from the website

Founded in 2007, Catalent Pharma Solutions is one of the leading providers of advanced technologies to the pharmaceutical, biotechnology and consumer health industries in the world. It offers preclinical support, analytical, clinical manufacturing, packaging, regulatory consulting and drug delivery development services. The organization utilizes the GPEx technology, which provides a range of biologic cell line development services. It also features soft capsules under the Vegicaps and Zydis brands. Catalent Pharma Solutions offers a variety of pharmaceutical product development services. In addition, it produces biological products for preclinical and clinical studies. The organization's packaging solutions include DelPouch and DelStrip, which are unit-dose delivery systems for lotions, creams, ointments and thin film strips.

Royalty Pharma is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in life sciences, operating at the intersection of science, medicine, and investing. With over $30 billion in announced transactions since its founding, the firm has acquired 80 royalties and holds the number one position in the market. As a partner of choice in the biopharma ecosystem, Royalty Pharma offers tailored funding solutions and win-win partnerships, making it the leading partner funding innovation in life sciences with more than 60% global market share. Its unique business model provides investors with exposure to the best attributes of biopharma while minimizing industry challenges. Generated from the website